Rebecca L. Kelly

Characterization of a RAD51C-Silenced High Grade Serous Ovarian Cancer Model During PARP Inhibitor Resistance Development

Christian A. Ross, Hu Li, C. Scott, 2020, bioRxiv.

Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma

A. Oberg, A. Mansfield, S. Kaufmann, 2021, Cancer Research.

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance

Christian A. Ross, Hu Li, C. Scott, 2021, NAR cancer.

Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo

K. Flatten, S. Kaufmann, L. Karnitz, 2019, Scientific Reports.

Intra-S phase checkpoint kinase Chk1 dissociates replication proteins Treslin and TopBP1 through multiple mechanisms during replication stress

L. Karnitz, Y. Machida, C. Huntoon, 2022, The Journal of biological chemistry.

Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo

K. Flatten, S. Kaufmann, L. Karnitz, 2019, Scientific Reports.